Sri Sujala Drugs & Intermediates Private Limited
Produces and distributes various chemicals, drugs, and intermediates for pharmaceutical industry.
2021 | Hyderabad, Telangana (India) | Active
Sri Sujala Drugs & Intermediates Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
- Paid Up Capital ₹ 18.00 K
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Sri Sujala Drugs & Intermediates
Sri Sujala Drugs & Intermediates Private Limited (SSDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 March 2021 (Four years and one month 13 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 18.00 K , as per Ministry of Corporate Affairs (MCA) records.
Velecheti Sureshbabu and Padmaja Velecheti serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290TG2021PTC150062
- Company No.
150062
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Sri Sujala Drugs & Intermediates Private Limited
Explore comprehensive data for Sri Sujala Drugs & Intermediates Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Sri Sujala Drugs & Intermediates?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Velecheti Sureshbabu  | Director | 09-May-2022 | Current |
| Padmaja Velecheti | Director | 25-Mar-2021 | Current |
Financial Performance of Sri Sujala Drugs & Intermediates.
Enhance accessibility to Sri Sujala Drugs & Intermediates's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sri Sujala Drugs & Intermediates?
Unlock access to Sri Sujala Drugs & Intermediates's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Geoviq Lifesciences Private Limited
Velecheti Sureshbabu and Padmaja Velecheti are mutual person
- Mahalakshmi Laboratories Private Limited
Velecheti Sureshbabu and Padmaja Velecheti are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Sujala Drugs & Intermediates?
Sri Sujala Drugs & Intermediates has a workforce of 0 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Sujala Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Sujala Drugs & Intermediates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sri Sujala Drugs & Intermediates
Recent activity within the organization
- Annual General Meeting
Sri Sujala Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Sri Sujala Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Velecheti Sureshbabu was appointed as a Director was appointed as a Director on 09 May 2022 & has been associated with this company since 3 years .
- Director Appointment
Padmaja Rani Velecheti was appointed as a Director was appointed as a Director on 25 Mar 2021 & has been associated with this company since 4 years 1 month .
- Company Incorporation
Sri Sujala Drugs & Intermediates Private Limited was registered on 25 Mar 2021 with Roc Hyderabad & aged 4 years 1 month as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Sri Sujala Drugs & Intermediates Private Limited?
Sri Sujala Drugs & Intermediates Private Limited was incorporated on 25 Mar 2021.
What is authorized share capital and paid-up capital of Sri Sujala Drugs & Intermediates Private Limited?
The authorized share capital of Sri Sujala Drugs & Intermediates Private Limited is ₹ 0.90 M and paid-up capital is ₹ 18.00 K .
Who are the current board members & directors of Sri Sujala Drugs & Intermediates Private Limited?
Currently 2 directors are associated with Sri Sujala Drugs & Intermediates Private Limited.
- Velecheti Sureshbabu
- Padmaja Rani Velecheti
What is the registered address of Sri Sujala Drugs & Intermediates Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sri Sujala Drugs & Intermediates Private Limited is D.No. 2-22-1/25/13 Sai Sri Arcade, Flat No. 204 Part Bhagyanagar Colony India, Hyderabad, Telangana, 500072.
What is the corporate identification number (CIN) and company number of Sri Sujala Drugs & Intermediates Private Limited?
The corporate identification number (CIN) of Sri Sujala Drugs & Intermediates Private Limited is U24290TG2021PTC150062 and the company number is 150062 as per Ministry of Corporate Affairs (MCA).
When was the last Balance Sheet of Sri Sujala Drugs & Intermediates Private Limited filed with the ROC?
The most recent Balance Sheet for Sri Sujala Drugs & Intermediates Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
VL
Velicheti LakshmikanthDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India